Toggle Main Menu Toggle Search

Open Access padlockePrints

Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial

Lookup NU author(s): Dr Marianela SchiavaORCiD, Meredith JamesORCiD, Emerita Professor Katherine Bushby, Professor Michela GuglieriORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Publication metadata

Author(s): Clemens PR, Berglund A, Schiava M, James MK, McDermott MP, Bushby K, Lampa E, Rochford ETJ, Ward LM, Griggs RC, Hoffman EP, Guglieri M

Publication type: Article

Publication status: Published

Journal: Neurology

Year: 2026

Volume: 107

Issue: 1

Print publication date: 14/07/2026

Online publication date: 27/05/2026

Acceptance date: 24/02/2026

Date deposited: 15/06/2026

ISSN (print): 0028-3878

ISSN (electronic): 1526-632X

Publisher: Wolters Kluwer Health

URL: https://doi.org/10.1212/WNL.0000000000214756

DOI: 10.1212/WNL.0000000000214756

Data Access Statement: Anonymized data not published within this article will be made available upon reasonable request from any qualified investigator. Specifically, the original VISION-DMD data may be provided after a Data Summary Request at the CINRG website (cinrgresearch.org/publications/data-summary-requests/) and after proposal approval with a signed data access agreement.

PubMed id: 42202243


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
European Commission Horizons 2020 (grant agreement number 667078)
Muscular Dystrophy Association
National Institute of Neurologic Diseases and Stroke (grants NS061799 and NS061795)
NIH grants (National Institute of Neurological Disorders and Stroke R44NS095423; NICHD 5U54HD090254, NIAMS U34AR068616)
Parent Project for Muscular Dystrophy
Santhera Pharmaceuticals
Sarepta Therapeutics
PTC Therapeutics

Share